Clinical trial
Efficacy Of Eggshell-Derived Nanohydroxyapatite Based Mineralized Plasmatic Matrix Versus Xenogeneic Based Mineralized Plasmatic Matrix in Posterior Mandibular Socket Preservation: A Randomized Controlled Clinical Trial.
NCT07404098 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy Of Eggshell-Derived Nanohydroxyapatite Based Mineralized Plasmatic Matrix Versus Xenogeneic Based Mineralized Plasmatic Matrix in Posterior Mandibular Socket Preservation: A Randomized Controlled Clinical Trial.
- Lead sponsor
- Cairo University
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- January 1, 2025
- Completion date
- May 2, 2026
- Enrollment
- 34 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alveolar bone resorption, nano-hydroxyapatite, socket preservation, wound healing